Cargando…

Positive surgical margin’s impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96)

The oncological impact of positive surgical margins (PSM) after robot-assisted partial nephrectomy (RAPN) is still under debate. We compared PSM and Negative Surgical Margins (NSM) in terms of recurrence-free survival (RFS), metastasis-free survival (MFS) and overall survival (OS) after RAPN, and we...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrone, Arnoult, Bentellis, Imad, Bernhard, Jean-Christophe, Bensalah, Karim, Champy, Cécile, Bruyere, Franck, Doumerc, Nicolas, Olivier, Jonathan, Audenet, François, Parier, Bastien, Brenier, Martin, Long, Jean-Alexandre, Nouhaud, François-Xavier, Branger, Nicolas, Lang, Hervé, Charles, Thomas, Xylinas, Evanguelos, Waeckel, Thibaut, Gomez, Florie, Boissier, Romain, Rouget, Benjamin, Shaikh, Aysha, Chevallier, Daniel, Ambrosetti, Damien, Durand, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622828/
https://www.ncbi.nlm.nih.gov/pubmed/36316438
http://dx.doi.org/10.1038/s41598-022-23146-4
Descripción
Sumario:The oncological impact of positive surgical margins (PSM) after robot-assisted partial nephrectomy (RAPN) is still under debate. We compared PSM and Negative Surgical Margins (NSM) in terms of recurrence-free survival (RFS), metastasis-free survival (MFS) and overall survival (OS) after RAPN, and we identified predictive factors of PSM. Multi-institutional study using the UroCCR database, which prospectively included 2166 RAPN between April 2010 and February 2021 (CNIL DR 2013-206; NCT03293563). Two groups were retrospectively compared: PSM versus NSM. Prognostic factors were assessed using Kaplan–Meyer curves with log-Rank test, cox hazard proportional risk model and logistic regression after univariate comparison. 136 patients had PSM (6.3%) and 2030 (93.7%) had NSM. During a median follow-up of 19 (9–36) months after RAPN, 160 (7.4%) recurrences were reported. Kaplan–Meier curves and analysis suggested that RFS, MFS and OS were not affected by a PSM (p = 0.68; 0.71; 0.88, respectively). In multivariate analysis predictors of PSM were a lower RENAL score (p = 0.001), longer warm ischemia time (WIT) (p = 0.003) and Chromophobe Renal Cell Carcinoma (chrRCC) (p = 0.043). This study found no impact of PSM on RFS, MFS or OS, and predictors of PSM were the RENAL score, WIT and chrRCC.